Trichlormethiazide Production Cost Reports

The report provides a detailed analysis essential for establishing a Trichlormethiazide production plant. It encompasses all critical aspects necessary for Trichlormethiazide production, including the cost of Trichlormethiazide production, Trichlormethiazide plant cost, Trichlormethiazide production costs, and the overall Trichlormethiazide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Trichlormethiazide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Trichlormethiazide is a thiazide diuretic that is used to treat edema related to congestive heart failure. It works by reducing fluid overload that leads to increased excretion of sodium, chloride, potassium, and water. This promotes mild volume contraction and blood pressure normalisation.

It manages edema in hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, and chronic renal failure, as well as in cases induced by corticosteroid or estrogen therapy. It is utilised in hypertension, as monotherapy or in fixed-dose combinations (e.g., with reserpine or potassium-sparing agents), exerting antihypertensive effects. Also, it is used to manage renal hypercalciuria by boosting calcium reabsorption in the distal tubule, preventing stone formation.

The market for Trichlormethiazide is driven by increasing cases of hypertension, edema, heart failure, and renal disorders. The growth in ageing populations and rise in health awareness contribute to its demand as an important and less dominant option compared to generics like hydrochlorothiazide.

The industrial Trichlormethiazide procurement is affected by limited API suppliers, along with evaluations of cost-effectiveness in tenders, fixed-dose combinations, and formulary preferences for generics. Also, supply reliability to prevent shortages and total lifecycle costs, incorporating quality controls for its stable versions, impacts its sourcing. Other factors like regulatory compliance for filings, prior authorisations, reimbursement policies, and competition from safer modern alternatives further impact its availability.

Raw Material for Trichlormethiazide Production

According to the Trichlormethiazide production plant project report, the key raw materials used in the production of Trichlormethiazide include 4-Amino-6-Chloro-m-Benzenedisulfonamide- Dichloroacetaldehyde.

Production Process of Trichlormethiazide

The extensive Trichlormethiazide production cost report consists of the following major industrial production process:

1. From 4-Amino-6-Chloro-m-Benzenedisulfonamide: The production of Trichlormethiazide involves a reaction between 4-amino-6-chloro-m-benzenedisulfonamide and dichloroacetaldehyde. In this process, 4-Amino-6-Chloro-m-Benzenedisulfonamide reacts with dichloroacetaldehyde under controlled conditions. It involves acidic catalysis to facilitate cyclisation and form the benzothiadiazine ring system. This process yields Trichlormethiazide, which is separated and purified to get pure Trichlormethiazide as the final product.

Trichlormethiazide is a white crystalline powder with a slight odour. It has a molecular formula of C8H8Cl3N3O4S2 and a molecular weight of 380.66 g/mol. Its XLogP3 is between 0.6-0.88, which makes it moderately lipophilic. It has 3 hydrogen bond donors, 7 acceptors, 2 rotatable bonds, and a topological polar surface area of around 118-135 Ų. It has a melting point at 248-270 degree Celsius and has a density of 1.75 g/cm³. It has a refractive index of 1.60 and a boiling point of 631 degree Celsius. It is slightly soluble in DMSO, methanol, and acetone, insoluble in water, and stable at room temperature in dark and inert conditions. It has a benzothiadiazine ring with a chloro at C-6, a dichloromethyl at C-3, and a sulfonamide at C-7.